Hoffmann-LaRoche, Inc. v. Weinberger
United States District Court for the District of Columbia
425 F. Supp. 890 (1975)

- Written by Alex Ruskell, JD
Facts
The Food and Drug Administration (FDA) had a policy for “me-too drugs” that allowed the sale of me-too drugs without the approval of a full new-drug application (NDA). Me-too drugs were chemically equivalent to pioneer drugs that had already received approved NDAs, and the FDA believed a full NDA for me-too drugs was unnecessary because of the FDA’s limited compliance resources and because the need to police such drugs was minimal. Hoffmann-LaRoche, Inc. (plaintiff) sued, arguing it had to wait for full NDA approval to market its drug but another manufacturer who made a me-too version of the drug only had to file an abbreviated NDA.
Rule of Law
Issue
Holding and Reasoning (Green, J.)
What to do next…
Here's why 832,000 law students have relied on our case briefs:
- Written by law professors and practitioners, not other law students. 46,500 briefs, keyed to 994 casebooks. Top-notch customer support.
- The right amount of information, includes the facts, issues, rule of law, holding and reasoning, and any concurrences and dissents.
- Access in your classes, works on your mobile and tablet. Massive library of related video lessons and high quality multiple-choice questions.
- Easy to use, uniform format for every case brief. Written in plain English, not in legalese. Our briefs summarize and simplify; they don’t just repeat the court’s language.